Tsutsumi Satoshi, Oki Eiji, Ida Satoshi, Ando Koji, Kimura Yasue, Saeki Hiroshi, Morita Masaru, Kusumoto Tetsuya, Ikeda Tetsuo, Maehara Yoshihiko
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Case Rep Gastroenterol. 2013 Dec 13;7(3):516-21. doi: 10.1159/000357591. eCollection 2013 Sep.
Gastric cancer with peritoneal dissemination may be diagnosed as unresectable. More recently, as a result of progress in chemotherapy, some patients with peritoneal dissemination have exhibited extended survival. We report on our experience with three patients in whom induction chemotherapy allowed for totally laparoscopic total gastrectomy (TLTG). All three patients were diagnosed as having advanced gastric cancer with peritoneal dissemination using staging laparoscopy. As induction chemotherapy, S-1 combined with cisplatin was administered to two patients and trastuzumab plus capecitabine combined with cisplatin to one patient. TLTG was performed in all patients and there were no postoperative complications. Adjuvant chemotherapy was initiated within 3 weeks after surgery in all three patients. Laparoscopic gastrectomy undertaken after induction chemotherapy was found to be effective and safe; this treatment has the potential to achieve good treatment outcomes in patients with stage IV gastric cancer.
伴有腹膜播散的胃癌可能被诊断为无法切除。最近,由于化疗取得进展,一些腹膜播散患者的生存期有所延长。我们报告了3例患者的治疗经验,这3例患者经诱导化疗后接受了完全腹腔镜全胃切除术(TLTG)。所有3例患者均经分期腹腔镜检查诊断为伴有腹膜播散的进展期胃癌。作为诱导化疗,2例患者接受S-1联合顺铂治疗,1例患者接受曲妥珠单抗加卡培他滨联合顺铂治疗。所有患者均接受了TLTG,且无术后并发症。所有3例患者均在术后3周内开始辅助化疗。结果发现,诱导化疗后进行腹腔镜胃切除术有效且安全;这种治疗方法有可能使IV期胃癌患者获得良好的治疗效果。